Drug intelligence / Profile preview

naphazoline + chlorphenamine

Development stage
Unknown
Lead developer
Qualiphar
Modality
Small Molecules
Administration
Intranasal
01

Overview

Vasocedine is a combination pharmaceutical product primarily used as a nasal decongestant and antihistamine. It contains naphazoline, a sympathomimetic amine that acts as a potent vasoconstrictor by stimulating alpha-adrenergic receptors in the nasal mucosa, thereby reducing swelling and congestion. The second component, chlorphenamine, is a first-generation antihistamine that acts as a competitive antagonist at H1 histamine receptors, helping to alleviate allergic symptoms such as sneezing and rhinorrhea. The product is commonly marketed in Belgium by Qualiphar and has been the subject of formulation research at institutions like Ghent University (Universiteit Gent), particularly regarding nasal drug delivery systems.

Brand names
Vasocedine
Other names
naphazoline nitrate + chlorphenamine maleate
02

Targets

ADRA1A (α1A)ADRA2A (α2A)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on naphazoline + chlorphenamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on naphazoline + chlorphenamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call